{"id":"https://openalex.org/W2890099035","doi":"https://doi.org/10.1200/jco.2018.36.15_suppl.tps4147","title":"Pembrolizumab-based therapy in previously treated high grade extrapulmonary neuroendocrine carcinomas.","display_name":"Pembrolizumab-based therapy in previously treated high grade extrapulmonary neuroendocrine carcinomas.","publication_year":2018,"publication_date":"2018-05-20","ids":{"openalex":"https://openalex.org/W2890099035","doi":"https://doi.org/10.1200/jco.2018.36.15_suppl.tps4147","mag":"2890099035"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2018.36.15_suppl.tps4147","doi":"https://doi.org/10.1200/jco.2018.36.15_suppl.tps4147","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2018.36.15_suppl.tps4147","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-3","medline","norway-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Claire Hooker","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Claire Hooker","raw_affiliation_strings":["University of California, San Francisco, San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California, San Francisco, San Francisco, CA;","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114950423","display_name":"Jennifer Ang Chan","orcid":"https://orcid.org/0000-0003-2523-9598","observed_orcids":["https://orcid.org/0000-0003-2523-9598"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jennifer A. Chan","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA;","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081123075","display_name":"Rahul Raj Aggarwal","orcid":"https://orcid.org/0000-0001-7003-7982","observed_orcids":["https://orcid.org/0000-0001-7003-7982"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]},{"id":"https://openalex.org/I4210167126","display_name":"UCSF Helen Diller Family Comprehensive Cancer Center","ror":"https://ror.org/05yndxy10","country_code":"US","type":"facility","lineage":["https://openalex.org/I180670191","https://openalex.org/I4210110664","https://openalex.org/I4210167126"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rahul Raj Aggarwal","raw_affiliation_strings":["UC San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UC San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA;","institution_ids":["https://openalex.org/I180670191","https://openalex.org/I4210167126"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009409407","display_name":"Pelin Cinar","orcid":"https://orcid.org/0000-0002-1247-353X","observed_orcids":["https://orcid.org/0000-0002-1247-353X"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Pelin Cinar","raw_affiliation_strings":["University of California San Francisco, San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California San Francisco, San Francisco, CA;","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112323440","display_name":"Tom Hope","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210167126","display_name":"UCSF Helen Diller Family Comprehensive Cancer Center","ror":"https://ror.org/05yndxy10","country_code":"US","type":"facility","lineage":["https://openalex.org/I180670191","https://openalex.org/I4210110664","https://openalex.org/I4210167126"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tom Hope","raw_affiliation_strings":["UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA;","institution_ids":["https://openalex.org/I4210167126"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079381108","display_name":"Kanti Pallav Kolli","orcid":"https://orcid.org/0000-0001-7820-6082","observed_orcids":["https://orcid.org/0000-0001-7820-6082"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kanti Kolli","raw_affiliation_strings":["University of California, San Francisco, San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California, San Francisco, San Francisco, CA;","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100425554","display_name":"Li Zhang","orcid":"https://orcid.org/0000-0002-3617-2627","observed_orcids":["https://orcid.org/0000-0002-3617-2627","https://orcid.org/0000-0003-2756-2620"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Li Zhang","raw_affiliation_strings":["University of California San Francisco, San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California San Francisco, San Francisco, CA;","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040007547","display_name":"Susan Calabrese","orcid":"https://orcid.org/0009-0007-2902-3651","observed_orcids":["https://orcid.org/0009-0007-2902-3651"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Susan Calabrese","raw_affiliation_strings":["University of California, San Francisco, San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California, San Francisco, San Francisco, CA;","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004633925","display_name":"Jennifer Ann Grabowsky","orcid":"https://orcid.org/0000-0003-4871-0741","observed_orcids":["https://orcid.org/0000-0003-4871-0741"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]},{"id":"https://openalex.org/I4210167126","display_name":"UCSF Helen Diller Family Comprehensive Cancer Center","ror":"https://ror.org/05yndxy10","country_code":"US","type":"facility","lineage":["https://openalex.org/I180670191","https://openalex.org/I4210110664","https://openalex.org/I4210167126"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jennifer Ann Grabowsky","raw_affiliation_strings":["UC San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UC San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA;","institution_ids":["https://openalex.org/I180670191","https://openalex.org/I4210167126"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070632479","display_name":"Jenna Zhang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jenna Zhang","raw_affiliation_strings":["University of California, San Francisco, San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California, San Francisco, San Francisco, CA;","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073970384","display_name":"Lawrence H. Fong","orcid":"https://orcid.org/0000-0002-6428-428X","observed_orcids":["https://orcid.org/0000-0002-6428-428X"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lawrence Fong","raw_affiliation_strings":["University of California, San Francisco, San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California, San Francisco, San Francisco, CA;","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059768717","display_name":"Nitya Prabhakar Raj","orcid":"https://orcid.org/0000-0002-1385-9995","observed_orcids":["https://orcid.org/0000-0002-1385-9995"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nitya Prabhakar Raj","raw_affiliation_strings":["Memorial Sloan Kettering Cancer Center, New York, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan Kettering Cancer Center, New York, NY;","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5033960518","display_name":"Emily K. Bergsland","orcid":"https://orcid.org/0000-0001-7754-6552","observed_orcids":["https://orcid.org/0000-0001-7754-6552"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Emily K. Bergsland","raw_affiliation_strings":["University of California, San Francisco, San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California, San Francisco, San Francisco, CA;","institution_ids":["https://openalex.org/I180670191"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"36","issue":"15_suppl","first_page":"TPS4147","last_page":"TPS4147"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10754","display_name":"Neuroendocrine Tumor Research Advances","score":0.9452999830245972,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10754","display_name":"Neuroendocrine Tumor Research Advances","score":0.9452999830245972,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.014700000174343586,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12226","display_name":"Neuroblastoma Research and Treatments","score":0.009499999694526196,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pembrolizumab","display_name":"pembrolizumab","score":0.9259999990463257},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.8820000290870667},{"id":"https://openalex.org/keywords/irinotecan","display_name":"irinotecan","score":0.9480000138282776},{"id":"https://openalex.org/keywords/paclitaxel","display_name":"paclitaxel","score":0.9980000257492065},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.6169999837875366},{"id":"https://openalex.org/keywords/tcr-repertoire","display_name":"T cell receptor repertoire","score":0.9679999947547913},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.6840000152587891},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.7870000004768372},{"id":"https://openalex.org/keywords/safety","display_name":"safety","score":0.48399999737739563}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9159447550773621},{"id":"https://openalex.org/C2780057760","wikidata":"https://www.wikidata.org/wiki/Q13896859","display_name":"Pembrolizumab","level":4,"score":0.829369068145752},{"id":"https://openalex.org/C2780259306","wikidata":"https://www.wikidata.org/wiki/Q412197","display_name":"Irinotecan","level":4,"score":0.7071857452392578},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6481851935386658},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5760261416435242},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5573333501815796},{"id":"https://openalex.org/C2778342957","wikidata":"https://www.wikidata.org/wiki/Q1711744","display_name":"Merkel cell carcinoma","level":3,"score":0.4519117772579193},{"id":"https://openalex.org/C2780030458","wikidata":"https://www.wikidata.org/wiki/Q7041828","display_name":"Nivolumab","level":4,"score":0.4373721480369568},{"id":"https://openalex.org/C2779384505","wikidata":"https://www.wikidata.org/wiki/Q17007513","display_name":"Concomitant","level":2,"score":0.4243777394294739},{"id":"https://openalex.org/C146357865","wikidata":"https://www.wikidata.org/wiki/Q1123245","display_name":"Stage (stratigraphy)","level":2,"score":0.4199506342411041},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3835040032863617},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.37269270420074463},{"id":"https://openalex.org/C2777546739","wikidata":"https://www.wikidata.org/wiki/Q33525","display_name":"Carcinoma","level":2,"score":0.3271947205066681},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.29739561676979065},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.0},{"id":"https://openalex.org/C151730666","wikidata":"https://www.wikidata.org/wiki/Q7205","display_name":"Paleontology","level":1,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2018.36.15_suppl.tps4147","doi":"https://doi.org/10.1200/jco.2018.36.15_suppl.tps4147","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2018.36.15_suppl.tps4147","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-3","medline","norway-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","score":0.8299999833106995,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4296634783","https://openalex.org/W2155654588","https://openalex.org/W2296139876","https://openalex.org/W4281648276","https://openalex.org/W3185931698","https://openalex.org/W2957427793","https://openalex.org/W2811288290","https://openalex.org/W2415283090","https://openalex.org/W2948845624","https://openalex.org/W4308384320"],"abstract_inverted_index":{"TPS4147":[0],"Background:":[1],"The":[2],"efficacy":[3,36,50],"of":[4,53,68,93,127,148,171,184,194,223,228,284,325,332],"immune":[5,299],"checkpoint":[6],"inhibitors":[7],"(CPI)":[8],"has":[9,31],"not":[10],"been":[11],"established":[12],"in":[13,37,56,110,329],"extrapulmonary":[14],"high":[15],"grade":[16],"neuroendocrine":[17],"carcinomas":[18],"(EP-HGNECs),":[19],"a":[20,145,169],"disease":[21],"for":[22,151,168,266],"which":[23,115],"additional":[24,105,163],"treatment":[25,312],"options":[26],"are":[27],"needed.":[28],"Pembrolizumab":[29],"(PEM)":[30],"demonstrated":[32],"safety":[33,52,146],"and":[34,51,73,159,248,297],"preliminary":[35],"small":[38],"cell":[39,233,300,303],"lung":[40],"cancer.":[41],"This":[42],"phase":[43],"2":[44,90,112],"study":[45,67,138],"aims":[46],"to":[47,117,141,154,202,256,268,310],"evaluate":[48],"the":[49,137],"PEM-based":[54],"therapy":[55],"biomarker":[57],"unselected":[58],"EP-HGNECs.":[59],"Methods":[60],"Design:":[61],"Open":[62],"label,":[63],"adaptive":[64],"Simon\u2019s":[65],"2-stage":[66],"PEM":[69,74,176,261],"alone":[70],"(Part":[71,85,113,210,214],"A)":[72,211],"plus":[75,177],"chemotherapy":[76,178],"(weekly":[77],"irinotecan":[78],"(IRI)":[79],"or":[80,212,238],"paclitaxel":[81],"(P);":[82],"dealers\u2019":[83],"choice)":[84],"B).":[86],"If":[87,132],"more":[88],"than":[89],"responses":[91],"out":[92],"14":[94,327],"pts":[95,150],"by":[96,278],"week":[97],"18":[98],"(stage":[99],"1":[100,158],"part":[101],"A),":[102,114],"then":[103,161,216],"21":[104],"patients":[106,164,173,328],"(pts)":[107],"will":[108,139,165,206],"enroll":[109],"stage":[111,330],"corresponds":[116],"H0":[118,185],"10%":[119,186],"vs.":[120,187],"H1":[121,188],"26%":[122],"at":[123,190],"type":[124,191,220],"I":[125,192,221,331],"error":[126,193,222],"0.05":[128,195],"with":[129,144,175,196,218,235],"power":[130,197,205],"80%.":[131,198],"there":[133],"is":[134],"insufficient":[135],"activity,":[136],"proceed":[140],"Part":[142,333],"B,":[143],"lead-in":[147],"6-12":[149],"IRI/PEM":[152],"(up":[153],"two":[155],"dose":[156],"levels,":[157],"-1),":[160],"16":[162],"be":[166,207],"accrued":[167],"total":[170],"22":[172],"treated":[174],"based":[179],"on":[180],"one-side":[181],"binomial":[182],"test":[183],"31%":[189],"Total":[199],"N":[200],"needed":[201],"attain":[203],"80%":[204],"either":[208],"35":[209,269],"36-42":[213],"A":[215,334],"B)":[217],"overall":[219,286],"0.1.":[224],"Key":[225],"eligibility:":[226],"EP-HGNEC":[227],"all":[229],"sites":[230],"(excluding":[231],"Merkel":[232],"carcinoma)":[234],"progression":[236],"during":[237],"after":[239],"first":[240],"line":[241],"systemic":[242],"therapy,":[243],"no":[244],"prior":[245],"CPI,":[246],"bilirubin":[247],"creatinine":[249],"\u22641.5x":[250],"ULN,":[251],"ECOG":[252],"PS":[253],"0-1,":[254],"agreeable":[255],"baseline":[257,295,309],"tumor":[258,298,315],"biopsy.":[259],"Treatment:":[260],"200":[262],"mg":[263],"IV":[264],"Q21days":[265],"up":[267],"treatments.":[270],"Primary":[271],"endpoint":[272],"(EP):":[273],"Overall":[274],"radiographic":[275],"response":[276],"rate":[277],"RECIST1.1.":[279],"Secondary":[280],"EP:":[281,291],"Safety,":[282],"duration":[283],"response,":[285],"survival,":[287],"progression-free":[288],"survival.":[289],"Exploratory":[290],"irRECIST":[292],"v":[293],"RECIST1.1,":[294],"PBMC":[296],"profiles,":[301],"T":[302],"receptor":[304],"(TCR)":[305],"repertoires":[306],"change":[307],"from":[308],"post":[311],"time":[313],"points,":[314],"mutation":[316],"profile,":[317],"Ki67":[318],"index,":[319],"PD-L1":[320],"expression.":[321],"Current":[322],"enrollment:":[323],"5":[324],"planned":[326],"(6/2017-present).":[335],"Clinical":[336],"trial":[337],"information:":[338],"NCT03136055.":[339]},"counts_by_year":[{"year":2021,"cited_by_count":1}],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2025-10-10T00:00:00"}